ArticleArthritis & rheumatology (Hoboken, N.J.)Published
Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Arthritis & rheumatology (Hoboken, N.J.)
- Published
- Topic
- Clinical care
- PubMed ID
- 43012507
- Added to directory
- Source checked